WebSite > Hangzhou ICH Biofarm Co., Ltd

Hangzhou ICH Biofarm Co., Ltd

  • Company Name Hangzhou ICH Biofarm Co., Ltd
  • Tel -+86-0571-28186870;
  • Email sales@ichemie.com
  • WebSite http://www.ichemie.com/
  • CB Index 58
  •       Our company specializes in the research, development and production of APIs and pharmaceutical intermediates. At the same time, our core R&D team has more than 20 years of drug R&D experience. Under the support of a good research and development environment and a professional technical team, our company has obtained rich experience and outstanding achievements of new drugs and generic drugs projects. On the one hand, we are focused on the research and development and the optimization of production processes of generic drugs such as anti-viral and anti-malaria. On the other hand, we are also committed to the cooperative development of innovative drugs in the fields of respiratory system and hypoglycemia. We can provide technical support in all key links of drug research and development for drug production and distribution companies.
Hangzhou ICH Biofarm Co., Ltd Product List
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Tamsulosin
  • MF C20H28N2O5S
  • CAS 106133-20-4
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Elobixibat
  • MF C36H45N3O7S2
  • CAS 439087-18-0
  •  
  • Product Name Relugolix
  • MF C29H27F2N7O5S
  • CAS 737789-87-6
  •  
  •  
  •  
  •  
  • Product Name Azathramycin
  • MF C37H70N2O12
  • CAS 76801-85-9
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Revefenacin
  • MF C35H43N5O4
  • CAS 864750-70-9
  •  
  • Product Name Doramectin
  • MF C50H74O14
  • CAS 117704-25-3
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name Omarigliptin
  • MF C17H20F2N4O3S
  • CAS 1226781-44-7
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •